Altogether, these preclinical and in vitro findings demonstrate that, mechanistically, adiponectin may act through anti-inflammatory, antioxidant, insulin-sensitizer, pro-adipogenic and endothelium-protective effects under inflammatory conditions, helping to limit metabolic and vascular complications during obesity (Figure 1). Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.